Generally, the Cancer Drug List comprises of drugs that are clinically proven and more cost-effective in treating a particular cancer.

 

A drug is clinically proven if it is registered with the Health Sciences Authority (HSA) for the particular clinical indication and has met the required standards of safety, quality and efficacy. A drug is cost effective if it provides good value in treating the particular cancer as compared to the existing standard of care, in terms of health benefits to the patient and cost.